MENA

Auto Added by WPeMatico

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages National Instruments Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NATI

NEW YORK, Jan. 20, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of National Instruments Corporation (NASDAQ: NATI) between May 25, 2022 and January 17, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT: If […]

Read More »

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MVST, MVSTW

NEW YORK, Jan. 20, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Microvast Holdings, Inc. (NASDAQ: MVST, MVSTW) between October 19, 2022 and November 20, 2023, both dates inclusive (the “Class Period”), of the important February 5, 2024 lead plaintiff deadline. SO WHAT: […]

Read More »

ROSEN, LEADING INVESTOR COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MSS

NEW YORK, Jan. 20, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Maison Solutions Inc. (NASDAQ: MSS): (1) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Maison Solutions’ October 2023 initial public offering […]

Read More »

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INSP

NEW YORK, Jan. 20, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline. SO WHAT: […]

Read More »

Nyxoah Announces 2024 Strategic Priorities

Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic […]

Read More »

EB5 Capital’s 225 North Calvert (JF15) Project Receives I-829 Approvals

WASHINGTON, Jan. 11, 2024 (GLOBE NEWSWIRE) — EB5 Capital, a prominent leader in the EB-5 investment industry, is pleased to announce that investors in its 225 North Calvert (JF15) project have started receiving I-829 approvals from the United States Citizenship and Immigration Services (USCIS). USCIS issues I-829 approvals, or permanent residency, to investors who have […]

Read More »

Quantexa Partners with the Anti-Human Trafficking Intelligence Initiative (ATII) to Intensify the Fight Against Human Trafficking

Quantexa to provide category-leading AI-enabled technology, training, and industry expertise to ATII to improve how data is used in the identification and investigation of human trafficking NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Today, Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced its official corporate sponsorship […]

Read More »